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Abstract
Purpose: The clinical target volume (CTV) of post-operative radiotherapy for soft tissue sarcoma of the limbs
conventionally includes the whole of the transverse cross-section of the affected anatomical compartment. In the anterior
thigh sartorius appears to lie within its own fascial compartment and can be safely excluded. We investigated the potential
impact of omitting sartorius from the anterior muscle compartment on patients with soft tissue sarcoma of the thigh.
Patients and methods: We used the planning CT data from six patients who had previously received post-operative
radiotherapy for soft tissue sarcoma of the thigh. The anterior compartments were outlined twice, initially including and
then excluding the sartorius muscle. The volumes of the anterior compartment (i.e., the CTVs), both with and without
sartorius, and the corresponding planning target volumes (PTVs) were calculated. Treatment plans were prepared for each
PTV. For both volumes the unirradiated normal tissue corridor was outlined on each CT slice. The volume and
circumference of the unirradiated corridor were then calculated.
Results: For all six patients there was an important improvement in normal tissue sparing by excluding sartorius. The
mean reduction in volume of the anterior compartment when sartorius was excluded was 10% (95% Confidence Interval
8–12%), whilst the mean decrease in PTV was 11% (95% CI 7–14%). There was a substantial increase in the volume of the
unirradiated normal tissue corridor, with a mean value of 77% (95% CI 41–114%) when sartorius was excluded.
In addition, the percentage increase in the size of the unirradiated normal tissue corridor, expressed as a percentage of
the whole leg circumference, was 10% (95% CI 8–13%). When sartorius was included in the anterior compartment,
the circumference of the unirradiated corridor was less than one-third of the whole leg circumference in four of the six
patients. When sartorius was excluded, the circumference of the unirradiated corridor was greater than one-third of the leg
circumference over the entire length of the target volume in all patients.
Discussion: It is essential to know the anatomy of the sartorius muscle to be able to exclude it from the anterior
compartment. The increase in the size of the normal tissue corridor when sartorius is excluded should deliver clinical
advantage by decreasing the normal tissue adverse effects.
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Introduction
Post-operative radiotherapy for soft tissue sarcoma of
the limb conventionally involves irradiation of the
entire transverse cross-section of the affected anato-
mical compartment. Inclusion of sartorius in the
anterior compartment of the thigh will result in a
larger clinical target volume for patients receiving
radiotherapy after surgical removal of an anterior
tumour. This is especially marked because the
sartorius muscle becomes progressively more
medial and posterior as it runs distally, and therefore
determines the posterior limit of the anterior
compartment in the lower half of the thigh. If
sartorius is excluded from the anterior compartment,
parallel opposed fields used to deliver the radio-
therapy can be shifted anteriorly. This means that
considerably less normal tissue is treated (Figure 1).
An anatomical investigation was performed in our
institution to discover whether the sartorius muscle
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is surrounded by a fascial membrane [1]. In all
cases sartorius was enclosed within a fascial sheath of
its own.
As a result of this anatomical investigation, we
sought to evaluate the effect of omitting sartorius
from the CTV for anterior compartment
radiotherapy. The CT data of six patients with
sarcoma were reviewed and radiotherapy plans were
prepared to treat the anterior compartment of the
thigh including and excluding sartorius.
Patients and methods
The radiotherapy planning CT scans of six patients
with soft tissue sarcoma of the limb were reviewed.
Four of these patients had in fact been treated for
posterior compartment tumours. Five of the six
patients were male. The mean age of the patients was
59.8 years (range 40–78 years).
For each patient, we outlined the anterior com-
partment on each of the CT slices, initially including
and then excluding the sartorius muscle. This
anterior compartment was therefore assumed to
be the clinical target volume (CTV). The length
of the CTV was assumed to be the same as that of
the original plan. The planning target volume was
then created by expanding the CTV by 1 cm
isotropically. Full conformal radiotherapy plans
were prepared for each patient, including and
excluding the sartorius muscle. The planning
system used was our in-house Addenbrooke’s
Radiotherapy Planning System (ARPS). An addi-
tional tool was written into ARPS to enable
measurement of the circumference of the thigh and
normal tissue corridor.
The volume of the anterior compartments and
corresponding PTVs, including and excluding
sartorius, were calculated for each patient. The
unirradiated normal tissue corridor was outlined on
each CT slice and defined as the volume of normal
tissue, outside the projections of the treatment beams
or conformal blocks, which should receive less than
50% of the prescribed dose. The corridor was then
evaluated in two ways. Firstly, the total volume
of this corridor was calculated. Secondly, the length
of the skin surface in the unirradiated corridor
at each level was measured and expressed as a
percentage of the total leg circumference at that level.
Figure 1 demonstrates the radiotherapy plans with
sartorius excluded and included in the CTV.
Having measured the volumes of the anterior
compartment, PTV and unirradiated corridor with
and without sartorius, the change in volume for each
patient as a result of omitting sartorius could be
calculated. The mean increase in the skin length of
the unirradiated corridor, expressed as a percentage
of the whole leg circumference, was also calculated.
The mean changes in volume and circumference
for the six-patient group were calculated. Confidence
intervals were calculated using the binomial
approximation.
Results
Figure 2 shows the volumes of the anterior compart-
ment and planning target volume, both including
and excluding sartorius, for the six patients. The
volumes of the unirradiated corridor when sartorius
is included and excluded are displayed in Table I.
The changes in the length of the skin surface of the
unirradiated corridor, expressed as a percentage of
the whole leg circumference, are displayed inTable II.
It can be seen that, in four out of six cases, standard
planning would have spared less than one-third of
the circumference of the leg. Exclusion of sartorius
(a) (b)
Figure 1. (a) Radiotherapy plan with sartorius excluded from the CTV. LAO1 and RPO represent the left anterior oblique and right
posterior oblique field, respectively. (b) Radiotherapy plan with sartorius included in the CTV. LAO1 and RPO represent the left anterior
oblique and right posterior oblique field, respectively.
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increased the proportion of the circumference spared
to greater than one-third in all cases.
The mean changes in volume and circumference
are summarised in Table III. It can be seen that the
exclusion of sartorius from the anterior compartment
results in a 10% (95% CI 8–12%) decrease in the
volume of this compartment. This corresponds
to a large increase in volume of the unirradiated
corridor; the mean for the six patients was 77%
(95% CI 41–114%). The increase in the means of
the normal tissue corridor, expressed as a percentage
of the whole leg circumference, was 10% (95% CI
8–13%). The range of these means was 5–15%.
Discussion
The results of this study add to the findings of the
anatomical investigation undertaken in our depart-
ment [1]. This investigation, though limited to eight
legs in six individuals, demonstrated that the inter-
muscular septum does lie posterior to sartorius and
that sartorius is enclosed within a fascial sheath of its
own. It also confirmed the very thick nature of the
femoral sheath fascia, which would protect sartorius
above the adductor canal from invasion by a tumour
sited deep and posterior to it.
In all eight legs in the six individuals, there was
evidence of a fascial envelope around sartorius in
the upper thigh. Posteriorly, this is reinforced by the
thick fascia of the femoral sheath. In the lower half of
the thigh, in four out of six individuals, there was
clear evidence that this envelope continued distally.
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Figure 2. (a) The volume of the anterior compartment when sartorius is included and excluded from the anterior compartment. (b) The
volume of the planning target volume when sartorius is included and excluded from the anterior compartment.
Table I. The changes in volume of the normal tissue corridor
when sartorius is included and excluded from the anterior
compartment.
Volume of unirradiated corridor (ml)
Patient
With
sartorius
Without
sartorius
Percent
increase1
1 523 1226 134
2 1584 2238 41
3 2190 3161 44
4 1644 2888 76
5 571 1328 133
6 751 1024 36
1Percentage increase in the volume of the unirradiated corridor
when sartorius is excluded from the anterior compartment.
Post-operative radiotherapy: Sartorius included? 3
In the lower half of the thigh in two subjects the
femoral sheath fascia appeared to merge with an
aponeurotic layer on the surface of vastus medialis.
It is less definite that this layer would prevent
invasion of tumour, although qualitatively this layer
appeared to be as thick as the intermuscular septum,
suggesting that it could resist tumour invasion as well
as the septum.
Both studies suggest that the exclusion of the
sartorius muscle from the anterior compartment
results in a significant reduction in normal tissue
irradiated. This can be shown as an increase in both
the volume and circumference of the unirradiated
normal tissue corridor. This should therefore lead to
decreased normal tissue complications.
Several studies have shown that the functional
outcome after radiotherapy to the limb is related to
the radiotherapy volume and the size of the
unirradiated corridor [2–5]. The total dose and
dose per fraction of radiotherapy used is also a
significant factor in determining range of move-
ment, muscle power and limb function [2,4,6].
Stinson et al. [2] reviewed 145 patients who under-
went combined modality limb sparing therapy at
the National Cancer Institute for extremity soft
tissue sarcoma between 1975 and 1986. Oedema
and tissue induration was more common with
increasing field length. Chronic ulcer or infection
was more frequently seen in patients with lower
extremity tumours when more than 75% of the
extremity diameter was irradiated. Karasek et al. [3]
found that the volume irradiated to greater than
55 Gy significantly correlated with post-treatment
morbidity.
It has been recommended that the normal tissue
corridor should comprise at least one-third of the
circumference of the limb [7]. This was achieved
over the entire length of the target volume in all six
patients after the sartorius muscle was excluded
from the anterior compartment.
The importance of post-treatment function is
paramount in the management of soft tissue
sarcoma. A study of limb function and quality of
life in 40 patients with soft tissue sarcoma of the head
and neck, trunk, upper and lower extremity showed
that patients with lower limb tumours had the
greatest functional impairment [8]. A randomised
trial comparing preoperative and postoperative
radiotherapy used three conceptually different out-
come measures to evaluate function and health
status [9]. The presence of a lower extremity
tumour was predictive for a greater change in
both the Musculoskeletal Tumour Rating Scale
(MSTS) and the Toronto Extremity Salvage Score
(TESS). These outcome measures are evaluated
by the clinician and patient, respectively. This
study also suggests that both dose and field size are
important factors in determining morbidity and
function.
Although the functional consequences of limb
conserving treatment are good, the addition of
radiotherapy or chemotherapy to surgery has an
adverse impact. This may be especially signifi-
cant if both radiotherapy and chemotherapy are
Table II. The changes in skin circumference of the normal tissue corridor when sartorius is included and excluded from the anterior
compartment.
Skin circumference of unirradiated corridor (expressed as percentage of whole leg circumference)
With sartorius Without sartorius Percent increase1
Patient Min Mean Max Min Mean Max Min Mean Max
1 6 25 44 27 36 51 5 11 21
2 0 27 44 27 37 44 0 10 28
3 23 35 44 36 44 51 6 9 14
4 15 31 41 38 42 49 4 11 22
5 9 26 36 35 41 48 7 15 26
6 34 40 45 42 45 49 0 5 9
1Percentage increase in the skin circumference of the unirradiated corridor when sartorius is excluded from the anterior compartment.
Table III. Mean changes for the six-patient group in volume and circumference when sartorius is excluded
from the anterior compartment.
Sartorius excluded 95% Confidence intervals
Mean reduction in volume of anterior
compartment
10% 8–12%
Mean reduction in PTV 11% 7–14%
Mean increase in volume of unirradiated
corridor
77% 41–114%
Mean increase in circumference of unirradiated
corridor
10% 8–13%
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required. It is therefore essential that the target
volume and dose of radiotherapy be optimised.
Quality of life and limb function depend on
achieving good local control, radiotherapy dose
and technique [10,11].
In recent years some centres have changed from
the conventional practice of irradiating the entire
anatomical department to the use of planning
margins of 4–5 cm around the GTV in the transverse
plane. This is partly because high local control
rates have been achieved with brachytherapy,
despite tighter margins around the tumour [12–14].
Alektiar et al. [12] determined the target region by
adding 2.0 cm to the superior and inferior dimen-
sions of the tumour bed, with 1.5–2.0 cm added in
the medial and lateral directions, achieving local
control rates of 91% (95% CI 86–96%) with lower
extremity high grade lesions. Karakousis et al. [15]
have shown local control rates of 81% for selected
high grade adult soft tissue sarcomas, resected with
a relatively tight 2-cm clear margin, without the
addition of adjuvant radiotherapy. The same group
has reported a local control rate of 76% in those
considered to require radiotherapy after resection.
In contrast, Mundt et al. [6] report a local rate of
93% with margins of 5 cm or more, compared to
30% with margins less than 5 cm. Other experts
also favour wider margins [7,16], so this issue
remains unresolved.
Our study is small and the confidence intervals,
particularly for the change in volume of the
unirradiated corridor, are large. However, it can be
seen that in all cases there was a considerable
increase in the volume of the unirradiated corridor
when sartorius was excluded. Because four of the
patients had previously been treated for posterior
compartment tumours, it is possible that the amount
of normal tissue sparing has in fact been under-
estimated in this study. By excluding the sartorius
muscle, we can therefore decrease the size of the
anterior compartment. Since we have shown that
sartorius is protected by its own fascial sheath, the
muscle does not need to be included in the treatment
field for a low posterior tumour.
In our centre, sartorius is no longer included
routinely in the CTV for anterior compartment soft
tissue sarcomas. However, in some clinical situations
it may be necessary to include the muscle. For
example, sartorius must be included in the CTV
if pre-operative imaging suggests involvement of this
muscle. If there is any doubt about whether sartorius
is involved, it would appear prudent to include the
muscle in the CTV. In a seventh patient, who was
not included in the study, it was not possible to
define the sartorius muscle as it appeared to merge
with gracilis at the junction of the upper and middle
third of the thigh. In this patient the tumour was
located medially and therefore the medial scar may
have altered the tissue plane. Anatomy definition
is improved on MRI scanning and this imaging
modality can be very helpful when available.
MRI/CT fusion on modern planning systems may
help to accurately contour patients where the CT
images are not clear.
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